5 BIOTECH STOCKS WITH MAJOR UPCOMING CATALYSTS$PHAT $CYTK $ADGI $AGIO $ICPT Clinical-Stage companies offer an exciting investment opportunity with massive upside potential. Most of these companies bring new and highly differentiated approaches, advanced scientific knowledge and a zeal for innovation to the table.
The covered Companies have major upcoming catalysts such as an impending FDA approval, drug launch, data readouts, initiation of clinical trials and IND submission to look forward to.
Learn More: https://www.aviseanalytics.com/5-biotech-stocks-with-major-upcoming-catalysts/